Los Angeles, CA -- (SBWIRE) -- 08/21/2019 -- The global Hadron Therapy market is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data on the global Hadron Therapy market. The report equips players with useful information and suggests result-oriented ideas to gain a competitive edge in the global Hadron Therapy market. It shows how different players are competing in the global Hadron Therapy market and discusses about strategies they are using to distinguish themselves from other participants.
Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1138368/global-hadron-therapy-market
Market Competition
Each company assessed in the report is studied in relation to various factors such as product and application portfolios, market share, growth potential, future plans, and recent developments. Readers will be able to gain complete understanding and knowledge of the competitive landscape. Most importantly, the report sheds light on strategies that leading players are banking on to maintain their dominance in the global Hadron Therapy market. It shows how the market competition will change in the next few years and how players are preparing themselves to stay ahead of the curve.
Hadron Therapy Market Leading Players
Koninklijke Philips N.V.
Advanced Oncotherapy
Varian Medical Systems
Optivus Proton Therapy
Hitachi, Ltd.
Mevion Medical Systems
ProTom International
Mitsubishi Electric Corporation
Sumitomo Corporation
ProNova Solutions, LLC
The report answers important questions that companies may have when operating in the global Hadron Therapy market. Some of the questions are given below:
- What will be the size of the global Hadron Therapy market in 2025?
- What is the current CAGR of the global Hadron Therapy market?
- Which product is expected to show the highest market growth?
- Which application is projected to gain a lion's share of the global Hadron Therapy market?
- Which region is foretold to create the most number of opportunities in the global Hadron Therapy market?
- Will there be any changes in market competition during the forecast period?
- Which are the top players currently operating in the global Hadron Therapy market?
- How will the market situation change in the coming years?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global Hadron Therapy market?
Request Customization of Report at https://www.qyresearch.com/customize-request/form/1138368/global-hadron-therapy-market
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.